ALK-Abelló A/S
Research ALK-Abelló A/S (ALK-B) on Bullrun: market cap DKK 47.86B, P/E 35.5, dividend yield 0.8%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerALK-B
- ExchangeCO
- CountryDenmark
- SectorHealthcare
- IndustryBiotechnology
- CurrencyDKK
- Market capDKK 47.86B
- P/E35.5
- Dividend yield0.8%
- Financial periodQ1 2026
- RevenueDKK 1.77B
- Net incomeDKK 437.00M
- Free cash flowDKK 671.00M
- Gross margin69.3%
Valuation Snapshot
latest market cap is DKK 47.86B; P/E is 35.5; dividend yield is 0.8%.
Peer valuation comparison
Latest P/E is 35.47x versus a Healthcare sector median of 24.46x (45.0% above).
Latest dividend yield is 0.77% versus a Healthcare sector median of 2.11% (63.5% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | DKK 6.31B | DKK 1.20B | DKK 1.54B | 67.1% | 540 | DKK 1.24B | DKK 418.00M | DKK 6.57B |
| FY2024 | DKK 5.54B | DKK 815.00M | DKK 953.00M | 64.2% | 3.68 | DKK 589.00M | DKK 1.19B | DKK 5.68B |
| FY2023 | DKK 4.82B | DKK 486.00M | DKK 357.00M | 62.9% | 2.2 | DKK 474.00M | n/a | DKK 4.45B |
| FY2022 | DKK 4.51B | DKK 335.00M | DKK 118.00M | 61.9% | 1.51 | DKK 221.00M | n/a | DKK 3.99B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-24 | DKK 47.86B | 35.5 | 0.7% | 1.6 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 1.6 DKK, yield 0.8%.
About ALK-Abelló A/S
ALK-Abelló A/S, an allergy solutions company, develops treatments for respiratory allergy, anaphylaxis, and food allergy and new disease areas in the European Union, the United Kingdom, Norway, Switzerland, the United States, Canada, Japan, China, and internationally.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is ALK-Abelló A/S's market cap?
ALK-Abelló A/S's market capitalization is DKK 47.86B.
What is ALK-Abelló A/S's P/E ratio?
ALK-Abelló A/S's price-to-earnings (P/E) ratio is 35.5.
Does ALK-Abelló A/S pay a dividend?
ALK-Abelló A/S has a dividend yield of 0.8%.
What does ALK-Abelló A/S do?
ALK-Abelló A/S, an allergy solutions company, develops treatments for respiratory allergy, anaphylaxis, and food allergy and new disease areas in the European Union, the United Kingdom, Norway, Switzerland, the United States, Canada, Japan, China, and internationally.